ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95 | +13.1% | 29,850 | +76.1% | 0.01% | +14.3% |
| Q2 2023 | $84 | 0.0% | 16,950 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $84 | -21.5% | 16,950 | 0.0% | 0.01% | -30.0% |
| Q4 2022 | $107 | -99.9% | 16,950 | +61.4% | 0.01% | -9.1% |
| Q3 2022 | $113,000 | -8.1% | 10,500 | -2.8% | 0.01% | 0.0% |
| Q2 2022 | $123,000 | +25.5% | 10,800 | 0.0% | 0.01% | +37.5% |
| Q1 2022 | $98,000 | -39.1% | 10,800 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $161,000 | -51.1% | 10,800 | -15.6% | 0.01% | -57.1% |
| Q3 2021 | $329,000 | – | 12,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |